Copenhagen-based Neurescue, a medical device startup that claims to be pioneering improvements in cardiac arrest treatment, has secured a Series A round of 50 million Danish kroner (approximately 6.7 million euros).
The investment was led by London-based Westhill Capital.
West Hill Capital has over £20bn of advised transactions and specializes in fundraising, IPOs and M&A. The company executes small deals, with funding ranging from £1 million to £20 million.
“Saving the heart and spirit”
According to Neurescue, current CPR methods only replace 35% of blood flow, which is often insufficient for effective resuscitation and does not provide enough time for advanced treatments.
Cardiac arrest accounts for 15-20% of all deaths, but with existing treatments the survival rate is only 1 in 10. In the United States, sudden cardiac arrest accounts for 40 to 50 percent of all lives lost to heart disease.
Standard CPR and AEDs do not reach the blood pressure needed to resuscitate most patients and do not allow enough time for advanced interventions. Accidents are the leading cause of death for people under 45, with severe bleeding accounting for a third of deaths. An unmet need exists for improved tools to address these cases.
This is where Neurescue makes a difference.
The company specializes in cardiovascular solutions, particularly the world’s first computer-assisted balloon catheter for aortic occlusion. This technique aims to enhance blood flow to the brain and heart, increasing resuscitation rates and extending treatment time.
The nine-year-old company was founded by Dr. Habib Frost and received FDA approval for its NEURESCUE device two and a half years ago.
The NEURESCUE device consists of a catheter and control unit and features patented sensor guidance and self-inflation technology. A safety feedback system ensures accurate positioning, adjusts balloon pressure, and prevents damage.
In emergency situations, the device increases blood flow to the heart and brain within a minute, addressing critical scenarios with a simple and effective design.